Main

Nutrient restriction, pathologic and physiologic cues including accumulation of aged or toxic material, of misfolded proteins, pathogen attack and cell maturation or differentiation may activate lysosomal clearance of parts of intracellular organelles such as the endoplasmic reticulum (ER), the mitochondria and the Golgi complex1,2,3,4,5,6. These parts are physically separated from the bulk of the organelle, which must be preserved, and are delivered within degradative acidic organelles. ER-phagy, mitophagy and Golgiphagy (here collectively mentioned as organellophagy) are driven upon activation of membrane-bound organellophagy receptors (for example, the ER-phagy receptors FAM134B7, SEC62 (refs. 8,9), TEX264 (refs. 10,11), CCPG1 (ref. 12) and others (Fig. 1a); the mitophagy receptors FUNDC1 (refs. 13,14), BNIP3, BNIP3L/NIX15,16 and others (Fig. 1b); and the Golgiphagy receptors YIPF3 and YIPF4 (refs. 17,18) (Fig. 1c)). All membrane-bound organellophagy receptors display a cytoplasmic intrinsically disordered region (IDR) module (Fig. 1a–c, green) that engages lipidated LC3/GABARAP proteins via short consensus LC3-interacting region (LIR) motifs (Fig. 1a–c, grey boxes). The activation of organellophagy receptors has two major consequences: (1) the fragmentation of the homing organelle to separate portions to be degraded and (2) the delivery of the organelle fragments within acidic degradative organelles via macro-autophagy, micro-autophagy or LC3-dependent transport pathways1,2,6,19,20,21,22,23. While it has been clearly established that delivery of organelle portions within degradative compartments requires the engagement of LC3 proteins via cytoplasmic organellophagy receptors’ LIRs, how organelles are portioned is unclear. For ER-phagy, a crucial role has been ascribed to the membrane remodelling function of the reticulon homology domains (RHD) that tether members of the FAM134 family at the ER membrane7,23,24,25,26,27,28. However, membrane remodelling is not a conserved trait of membrane-tethering modules of organellophagy receptors. In fact, other ER-phagy, mitophagy and Golgiphagy receptors17,18 are anchored via conventional multi- or single-spanning transmembrane domains (Fig. 1a–c) that are not expected to promote membrane remodelling per se. Thus, a model assuming that the membrane-tethering modules of organellophagy receptors determine or give essential contribution to organelle fragmentation23 cannot be generalized. To clarify these issues, we investigated the consequences on ER and mitochondrial integrity of the expression at their limiting membranes of full-length, membrane-tethering or IDR modules of the ER-phagy receptors FAM134B, SEC62 and TEX264 and the mitophagy receptor FUNDC1.

Fig. 1: Membrane-bound organellophagy receptors.
figure 1

a, Schematics of the topology of ER-phagy receptors in mammalian (human, left) and yeast (S. cerevisiae, right) cells. RHD is shown in light blue, the blue rectangles show the conventional transmembrane domain, the green line shows the IDR and the LIR is shown in grey. b, Same as a for mitophagy receptors. IMS, intramembrane space. c, Same as a for mammalian Golgiphagy receptors. d, The length of IDR modules in amino acids. AA, amino acid. e, The net cumulative charge of cytoplasmic IDR modules at physiologic pH calculated using https://www.biosynth.com/peptide-calculator.

Our study shows that the membrane-anchoring domains of organellophagy receptors can be replaced by exogenous membrane anchors with no impact on organelle fragmentation and lysosomal delivery. This implies, for example, that the membrane remodelling activity of FAM134B is dispensable for execution of ER-phagy. We report that ER and mitochondrial fragmentation is controlled by the cytoplasmic IDR modules of the organellophagy receptors. Consistent with the concept of functional conservation on sequence divergency, the IDR modules of organellophagy receptors have different sequences but maintain conserved traits. Among them, we identify a net cumulative negative charge at physiologic pH, a length above the 47 residues and a minimal distance of the LIR from the membrane of 24 residues. Conservation of these and possibly other features that remain to be characterized make them interchangeable. Thus, IDR modules of ER-phagy receptors expressed at the outer mitochondrial membrane (OMM) trigger mitochondrial fragmentation and mitophagy; IDR modules of mitophagy receptors expressed at the ER membrane trigger ER fragmentation and ER-phagy.

Results

Membrane-anchoring and cytosolic IDR modules

The ER, the mitochondria and the Golgi complex display a large array of autophagy receptors at their limiting membrane1,4,21,29 (Fig. 1a–c). Organellophagy receptors are composed of a membrane-tethering module that spans the organelle membrane once or multiple times (Fig. 1a–c, blue boxes) and a cytoplasmic IDR module (Fig. 1a–c, green lines) that contains the LIR domain engaging LC3/GABARAP proteins (Fig. 1a–c, grey boxes). Mammalian FAM134 family members and RTN3L are anchored at the ER membrane with RHDs that only partially span the lipid bilayer, with intrinsic membrane remodelling activity (shown in curved regions of the ER membrane in Fig. 1a). All other organellophagy receptors are anchored at membranes via conventional transmembrane domains (Fig. 1a–c).

We notice that the IDR modules of mammals and yeast ER-phagy, mitophagy and Golgiphagy receptors have a length between 47 and 250 residues (Fig. 1d) and include a single LIR (Fig. 1a–c, grey boxes). The LIR of the mitophagy receptor FUNDC1 is placed at 24 residue distance from the last residue of the transmembrane anchor. All other organellophagy receptors’ LIRs are characterized by longer distances from the membrane of the homing organelles. The IDR module of RTN3L, a protein involved in endosome maturation30, spans over 800 residues and contains multiple LIRs1,4,5,20,21,31,32,33.

The IDR modules of organellophagy receptors have diverging sequences but are all characterized by net cumulative negative charge at physiologic pH (for example, −19.95 for SEC62IDR, −33.94 for FAM134BIDR, −13.96 for TEX264IDR, −3.93 for FUNDCIDR and −8 and −11.11 for YIPF3IDR and YIPF4IDR, respectively; Fig. 1e and https://www.biosynth.com/peptide-calculator). IDRs are often present in the proteome and a survey of the literature reveals that their functions include the processing of regulatory cues, molecular communication34 and, notably, sensing and driving membrane curvature35,36,37. For their role in organellophagy, nothing is known beyond a putative role in ER-phagy as spacers to bridge the distance between the ER membrane in rough ER subdomains covered by ribosomes and LC3 lipidated at the membrane of phagophores (for macro-autophagic pathways) or of endolysosomes (EL, for micro-autophagy or LC3-mediated delivery pathways)11.

Expression of ER-phagy receptors triggers ER-phagy

ER-phagy is activated by pleiotropic (for example, nutrient restriction) and ER-centric cues (for example, luminal accumulation of misfolded proteins, ER stress and ribosome stalling)1,20. These cues induce expression of individual or multiple ER-phagy receptors and/or increase their local concentration and activity upon derepression, post-translational modifications and/or formation of hetero- or homo-meric clusters8,12,24,25,27,38,39,40,41,42,43,44,45,46,47,48,49,50,51,52,53,54,55. The ectopic expression of ER-phagy receptors induces ER-phagy bypassing the need for activating exogenous or intrinsic cues and has been used to characterize their functions, their interactors and their regulation (for example, FAM134B7,53,56, SEC62 (refs. 8,9,57) and TEX264 (refs. 10,11,54)). Here, we first express Halo-tagged58,59,60 versions of FAM134B, SEC62 and TEX264 (Fig. 2, left) to compare their capacity to induce ER-phagy. Please note that in all figures, the 4 nm × 3 nm GFP (Fig. 3, green circles) or HaloTag barrels (Fig. 2, green circles)61 are drawn in approximate scale with the IDRs, where each amino acid contributes to the length of the unstructured IDR for an average of 0.38 nm (ref. 62). ER-phagy is monitored by confocal laser scanning microscopy (CLSM) in mouse embryonic fibroblasts (MEF) treated with Bafilomycin A1 (BafA1) to inhibit lysosomal hydrolases and preserve material (in this case, calnexin (CNX)-positive ER portions) delivered in the lumen of degradative LAMP1-positive EL63. Expression of FAM134B, SEC62 or TEX264 increases delivery of ER portions within LAMP1-positive EL (Fig. 2c,g,k) above the constitutive levels observed in mock-transfected cells (Fig. 2a). The variations in ER-phagy activity (that is, the accumulation of CNX-positive ER portions within LAMP1-positive EL upon inactivation of lysosomal hydrolases) are quantified with the deep learning tool LysoQuant developed in our lab64 (Fig. 2e,i,m). The expression of the membrane-anchoring modules of the ER-phagy receptors (FAM134BRHD (Fig. 2b,e), SEC62TMD (Fig. 2f,i) or TEX264TMD (Fig. 2j,m)) does not trigger ER delivery within EL. Likewise, the expression of versions of the full-length ER-phagy receptors carrying mutations that prevent engagement of LC3 proteins (-453DDFELLD458- to -AAAAAAA- amino acid substitution for FAM134BLIR (ref. 7) (Fig. 2d,e), -363FEMI366- to -AAAA- for SEC62LIR (ref. 8) (Fig. 2h,i) and -273FEEL276- to -AAAA- for TEX264LIR (refs. 10,11) (Fig. 2l,m)) does not trigger ER delivery within EL. To confirm the activation of an autophagic flux also in cells, where the lysosomal activity has not been inhibited (that is, in absence of BafA1 exposure), we made use of the HaloTag assay, which has been developed in our lab59,60,65,66,67. Briefly, MEF expressing the ER-phagy reporter HT17, a chimeric polypeptide of 37 kDa composed of a HaloTag tethered to the ER membrane with a 17-residue transmembrane domain68 (Fig. 2n, second panel from the top, lanes 1–11) were mock-transfected (Fig. 2n, lane 1) or were transfected with the same modules analysed in Fig. 2b–m tagged with a monomeric superfolder (sf)GFP moiety69. Lysosomal delivery of ER portions and the subsequent hydrolytic processing of the HT17 reporter generates a protease-resistant Halo fragment of about 33 kDa, whose fluorescence can be directly monitored in gel (Fig. 2n, third panel from the top)59,60,65,66,67. The HaloTag assay confirms the imaging data (Fig. 2a–m). Thus, expression of sfGFP-tagged FAM134B, SEC62 and TEX264 (Fig. 2n, top panel) triggers ER-phagy as shown by the generation of the Halo fragment (Fig. 2n, third panel from the top, lanes 3, 6 and 9), which requires hydrolytic lysosomal activity (that is, the cells exposure to BafA1 inhibits the generation of the Halo fragment, lane 11). The expression of FAM134BRHD (Fig. 2n, lane 2), SEC62TMD (lane 5), TEX264TMD (lane 8) or the expression of FAM134BLIR (Fig. 2n, lane 4), SEC62LIR (lane 7) and TEX264LIR (lane 10)) does not trigger ER-phagy as testified by the absence of the fluorescent Halo fragment.

Fig. 2: CLSM analyses of ER-phagy induction.
figure 2

a, Representative CLSM images of delivery of CNX-positive ER portions (red) to LAMP1-positive ELs (cyan) in mock-transfected MEF treated with 50 nM BafA1 and 100 nM TMR. Scale bar, 10 μm. The inset shows a 4× magnification of the merge image. b, Same as a in cells expressing FAM134BRHD-HALO (green, TMR). c, Same as b in cells expressing FAM134B-HALO. d, Same as c for FAM134BLIR-HALO. e, LysoQuant quantification of the percentage of CNX-loaded LAMP1-positive EL in ad (mock (n = 30 cells), FAM134BRHD-HALO (n = 32 cells), FAM134B-HALO (n = 26 cells), FAM134BLIR-HALO (n = 20 cells)). N = 3 biological replicates. fh, Same as bd in cells expressing SEC62TMD-HALO (n = 27 cells) (f), SEC62-HALO (n = 24 cells) (g) and SEC62LIR-HALO (n = 20 cells) (h). i, LysoQuant quantification of the percentage of CNX-loaded LAMP1-positive EL in fh. N = 3 biological replicates. Mock as in e. jl, Same as fi in cells expressing TEX264TMD-HALO (n = 13 cells) (j), TEX264-HALO (n = 27 cells) (k) and TEX264LIR-HALO (n = 18 cells) (l). m, LysoQuant quantification of the percentage of CNX-loaded LAMP1-positive EL in jl. N = 3 biological replicates. Mock as in e. A one-way ANOVA with Turkey’s multiple comparisons test was performed, with F = 190.1, 193.6 and 168 for e, i and m, respectively. Adjusted P value: ****P < 0.0001, n.s., not significant (P = 0.0643, 0.3035 and 0.8759 for n.s. in e, i and m, respectively). The mean bar is shown. n, In gel native GFP fluorescence (top) and HaloTag assay in cells expressing the ER-phagy reporter HT17 (second from top) of constructs from al showing Halo fragment formation (high contrast) upon expression of LC3-binding-competent ER-phagy receptors FAM134B (lane 3), SEC62 (lane 6) and TEX264 (lane 9). N = 1 biological replicate. Bottom: the Coomassie loading control.

Source data

Notably, as already shown by others in silico26 and double checked here in cellula by room temperature-transmission electron microscopy (RT-TEM) (Extended Data Fig. 1a–e), the membrane-anchoring RHD module of FAM134B has the intrinsic property of remodelling the ER membrane. However, the compartment remains connected by thin tubules (Fig. 4f,g, fluorescence recovery after photobleaching (FRAP) experiments, and Extended Data Fig. 1c, red arrowheads) as it has been observed upon overexpression of members of the conserved family of ER remodelling proteins that generate high ER membrane curvature such as reticulons or REEP proteins30,70,71,72,73,74,75,76,77,78,79. The membrane-anchoring modules of SEC62 and TEX264 do not remodel the ER membrane as shown by the ER ultrastructure in mock-transfected cells (Extended Data Fig. 1b), which remains unchanged in cells expressing SEC62TMD and TEX264TMD (Extended Data Fig. 1d,e). Altogether, these data confirm that the expression of ER-phagy receptors competent for LC3 engagement at the ER membrane induces ER-phagy bypassing the needs of external cues. Importantly, the induction of ER-phagy occurs independent of the capacity of the membrane-anchoring modules of the receptors to remodel the ER membrane.

As a separate note, individual ER-phagy receptors are located in and control lysosomal clearance of distinct ER subdomains (FAM134B for ER tubuli, SEC62 and TEX264 for ER sheets and outer nuclear membrane1,8,9,10,11,57,80,81). Notably, the distinct suborganellar localization is also observed upon cellular expression of the membrane-anchoring domains of the ER-phagy receptors lacking the cytoplasmic IDR modules. For example, the endogenous interactome of FAM134BRHD reveals its distribution in subdomains hosting proteins of the reticulon and REEP families (as reported for the full-length receptor56) (Extended Data Fig. 1f,g). The interactions of the SEC62TMD and of the TEX264TMD reveal their localization in ER sheets also containing subunits of the translocation machinery including the oligosaccharyltransferase complex and chaperones assisting protein folding (as reported for the full-length receptors8) (Extended Data Fig. 1f,g).

Expression of ER-phagy receptors IDR modules elicits ER-phagy

The finding that ER-phagy receptors expression induces ER-phagy (that is, ER fragmentation and delivery of ER portions within degradative LAMP1-positive organelles), independent of the capacity of their membrane-tethering modules to remodel the ER membrane, led us to verify the dispensability of the FAM134B, SEC62 and TEX264 membrane anchors to launch the catabolic programme. To verify this, we expressed in MEF the cytoplasmic IDR modules FAM134BIDR, SEC62IDR or TEX264IDR anchored at the ER membrane with a single-spanning transmembrane domain of 17 residues (T17)68. The chimeras were tagged with a luminal sfGFP (Fig. 3, schematics, and Extended Data Fig. 2). Induction of ER-phagy was assessed, as above, both with the imaging and with the HaloTag assays. Analyses by CLSM (Fig. 3a–g and Extended Data Fig. 2a–g for entire cells) and LysoQuant quantifications (Fig. 3h) show the enhanced lysosomal delivery of CNX-positive ER portions in cells expressing the three IDR modules (Fig. 3b,h for GT17-FAM134BIDR, Fig. 3c,h for GT17-SEC62IDR and Fig. 3d,h for GT17-TEX264IDR and Extended Data Fig. 2b–d) compared with cells that express the ER membrane targeted sfGFP that does not display a cytoplasmic IDR (GT17) (Fig. 3a,h and Extended Data Fig. 2a). The inactivation of the LC3-binding function of the three IDR modules abolishes delivery of ER portions within the LAMP1-positive EL (Fig. 3e–h and Extended Data Fig. 2e–g).

Fig. 3: Membrane-associated IDRs trigger ER-phagy.
figure 3

a, CLSM images of delivery of CNX-positive ER portions (red) to LAMP1-positive EL (cyan) upon the expression of GT17 in MEF treated with 50 nm BafA1. GT17 consists of a luminal GFP (G in the schematics on the left) tethered at the ER membrane with a transmembrane domain of 17 residues (T17)68. Schematics of GT17-FAM134BIDR, GT17-SEC62IDR and GT17-TEX264IDR chimeras and the control GT17 construct without the IDR are shown. Scale bars, 1 μm. b, Same as a, where cells express GT17-FAM134BIDR (that is, the GT17 moiety displaying the IDR module of FAM134B at the cytoplasmic face of the ER membrane (left)). c, Same as b for GT17-SEC62IDR. d, Same as b for GT17-TEX264IDR. eg, Same as bd for cells expressing GT17-FAM134BIDRLIR (e), GT17-SEC62IDRLIR (f) and GT17-TEX264IDRLIR (g) mutants. Please also refer to Extended Data Fig. 2a–g for micrographs of entire cells. h, LysoQuant quantification of LAMP1-positive EL accumulating CNX-positive ER portions in ag (n = 15, 21, 16, 19, 17, 16 and 19 cells), N = 3 biological replicates. A one-way ANOVA with Turkey’s multiple comparisons test was performed, F = 64.15. Adjusted P value: ****P < 0.0001. The mean bar is shown. i, GFP native in gel fluorescence and HaloTag assay showing enhanced delivery of ER-phagy reporter HT17 to hydrolytically active EL upon expression of GT17-SEC62IDR (lane 4), GT17-FAM134BIDR (lane 6) and GT17-TEX264IDR (lane 8), as demonstrated by the increase in Halo fragment (high contrast). N = 1 biological replicate. Bottom: the Coomassie loading control. j, IEM showing the localization of gold-labelled GT17-SEC62IDR in the lumen of ER and ER portions in the cytoplasm (red arrowheads) or within EL (blue arrowheads). The dashed line shows the EL limiting membrane. Scale bar, 500 nm. N = 1 biological replicate. k, Same as j for GT17-SEC62IDRLIR.

Source data

The dispensability of the ER-phagy receptors membrane-tethering modules for ER-phagy induction was confirmed with the HaloTag assay mentioned above that reports on the generation of the Halo fragment (Fig. 3i, third from the top) in cells with functional EL that express the membrane-bound, sfGFP-tagged IDR modules of SEC62 (Fig. 3i, lane 4), FAM134 (Fig. 3i, lane 6) and TEX264 (Fig. 3i, lane 8). The fragment is not produced in cells that express a membrane-tethered GT17 control protein lacking cytoplasmic IDR (Fig. 3i, third from the top, lane 2) or the IDR modules that cannot engage LC3 (lanes 5, 7 and 9, respectively).

Finally, the competence of membrane-tethered IDR modules to fragment the ER and to deliver ER portions within EL was also monitored with anti-GFP immunoelectron microscopy (IEM) in MEF treated with BafA1. The gold particles reveal the localization of the GFP moiety of the membrane-tethered GT17-SEC62IDR and of the GT17-SEC62IDRLIR chimeras in the lumen of the ER and of ER portions in the cytoplasm (Fig. 3j,k, red arrowheads). Notably, the cells that express the IDR module that can engage LC3 show GFP-positive ER portions also within the lumen of EL (Fig. 3j, blue arrowheads), whereas the cells that express the IDR module that cannot engage LC3 do not show GFP-positive ER portions within the lumen of EL (Fig. 3k). This confirms that LC3 engagement is required for lysosomal delivery.

Monitoring IDR modules-induced ER fragmentation

The detection of ER portions within LAMP1-positive EL in cells expressing full-length ER-phagy receptors (Fig. 2) or their IDR modules anchored at the ER membrane with a dissimilar transmembrane domain (Fig. 3 and Extended Data Fig. 2) indirectly reports on ER fragmentation, which is a prerequisite for ER portions being delivered within the degradative compartments. Direct monitoring of ER fragmentation (that is, the visualization of ER portions in the cytoplasm) is challenging due to the ultrastructure of the compartment and to the fact that the portions are delivered within EL for clearance. To overcome this hurdle and directly monitor the ER fragmentation function of ER-phagy receptor’s IDR modules, the experiments shown in Fig. 3 were repeated in MEF lacking ATG7 (Fig. 4a), where the absence of LC3 lipidation82 inhibits the delivery of ER portions within the LAMP1-positive degradative organelles7,8,9,10,11, thus preserving them in the cytoplasm.

Fig. 4: ER fragmentation in ATG7-KO MEF expressing the IDR module of SEC62.
figure 4

a, Left: a western blot (WB) demonstrating the KO of ATG7. The arrow indicates the band corresponding to ATG7. The stars represent the unspecific bands. WT, wild type. b, IEM micrograph showing the ER morphology in mock-transfected ATG7-KO MEF. N = 1 biological replicate. c, Same as b in a cell expressing GT17. The gold-labelled ER sheets are indicated with green arrowheads. d, An IEM micrograph showing fragmented ER in a cell expressing GT17-SEC62IDR. The red arrowheads indicate cytoplasmic ER fragments. e, Same as d in a cell expressing GT17-SEC62IDRLIR. Scale bars, 1 μm. The inset represents a magnification of 2×. f, Representative FRAP curves of ATG7-KO MEF expressing ER-lumen marker GFP–KDEL. In mock-transfected cells (black) the recovery of GFP–KDEL fluorescence is efficient. Expression of HT17 (violet) and FAM134BRHD does not notably affect the proportion of ER that recovers its fluorescence, indicating largely interconnected ER network. Expression of HT17-SEC62IDR and HT17-SEC62IDRLIR reduces the proportion of ER that recovers its fluorescence, indicating fragmented ER. g, A quantification of the fraction of GFP–KDEL fluorescence that is permanently lost after FRAP in f, N = 4 biological replicates for mock, N = 3 for HT17-SEC62IDR, HT17-SEC62IDRLIR and FAM134BRHD, N = 2 for HT17; n = 24, 14, 20, 18 and 18 cells. An ordinary one-way ANOVA with a Dunnett’s multiple comparisons test was performed, F = 11.74. ****P < 0.0001, ***P = 0.0003, P(mock versus HT17) = 0.6066, P(mock versus FAM134BRHD) = 0.8390; n.s., not significant. The mean bar is shown.

Source data

Analyses by RT-TEM of the ER ultrastructure in cells mock transfected (Fig. 4b), expressing membrane-bound sfGFP (GT17, Fig. 4c) or membrane-bound sfGFP displaying the IDR modules of SEC62 that can (GT17-SEC62IDR, Fig. 4d) or cannot engage LC3 proteins (GT17-SEC62IDRLIR, Fig. 4e), reveal that only the expression of GT17-SEC62IDR and of GT17-SEC62IDRLIR drives the formation of ER-derived vesicles visible in the cytoplasm (Fig. 4d,e, red arrowheads).

A FRAP assay of ER lumen connectivity performed with the HaloTagged variants of the same constructs (HT17, HT17-SEC62IDR and HT17-SEC62IDRLIR) confirms a substantial inhibition of fluorescence recovery in cells expressing the IDR modules SEC62IDR and SEC62IDRLIR (Fig. 4f,g, green curves), as compared with mock-transfected cells (Fig. 4f,g, black curve) and with cells expressing HT17 (Fig. 4f,g, violet curve). This is consistent with the RT-TEM images showing that expression of the IDR modules results in physical separation of ER portions from the bulk ER and shows that the LIR function of the IDR module is dispensable for organelle fragmentation. Notably, FRAP experiments also confirm that the expression of the RHD of FAM134B that induces ER remodelling and formation of ER constrictions (Extended Data Fig. 1c, red arrowheads) does not inhibit the recovery of the fluorescent signal, consistent with the incompetence of the RHD of FAM134B expressed alone in cellula to fragment the ER (Fig. 4f,g, blue curve).

ER-phagy receptors IDRs-driven mitophagy

Motivated by these findings and by the fact that also autophagy receptors at the limiting membrane of other organelles display cytoplasmic IDR modules with similar features (Fig. 1), we verified whether the IDR modules of ER-phagy receptors encode a signal driving lysosomal delivery of mitochondrial portions, when exposed at the limiting membrane of mitochondria. To this end, FAM134BIDR, SEC62IDR and TEX264IDR were expressed at the OMM. Briefly, MEF were mock-transfected (Fig. 5a) or were transiently transfected with a plasmid for expression of a sfGFP moiety targeted at the OMM by the transmembrane domain of the mitochondrial protein TOMM20 (Mito-GFP)83 (Fig. 5b). Alternatively, the cells were transfected with plasmids for expression of the same membrane-tethered sfGFP moiety displaying at the C-terminus SEC62IDR, FAM134BIDR or TEX264IDR modules (Fig. 5c,e,g), or the same IDR modules carrying a mutation in the LIR domain that prevents LC3 engagement (Fig. 5d,f,h and Extended Data Fig. 3a–j, for the same experiment replicated in HEK293 cells and for the control of LC3 binding). The cells were exposed to BafA1 to preserve the endogenous TOMM20-positive mitochondrial fragments delivered within endolysosomal degradative compartments63. In mock-transfected cells and in cells expressing the Mito-GFP at the OMM (Fig. 5a,b), a low percentage of the LAMP1-positive EL accumulates the endogenous mitochondrial TOMM20 protein marker (quantifications with LysoQuant in Fig. 5j), reporting on the constitutive lysosomal turnover of mitochondrial portions. Mitochondrial transplantation of the SEC62IDR, FAM134BIDR or TEX264IDR modules, enhances the delivery of the mitochondrial fragments within degradative LAMP1-positive EL (Fig. 5c,e,g,j). Mutations of the IDR’s LIR motifs that inhibit engagement of LC3 proteins (Fig. 5d,f,h,j) or transplantation of the ER-phagy receptors IDR modules at the OMM in MEF lacking ATG7, which are defective in LC3 lipidation (Extended Data Fig. 4) hamper the delivery of TOMM20-positive mitochondrial portions within the degradative LAMP1 compartment.

Fig. 5: Monitoring lysosomal delivery of fragmented mitochondria in wild-type MEF expressing the ER-phagy receptors IDR modules.
figure 5

a, Representative CLSM images of delivery of TOMM20-positive mitochondrial portions (red) to LAMP1-positive EL (cyan) in mock-transfected MEF treated with 50 nM BafA1 and 100 nM TMR. Scale bar, 10 μm. The inset shows a 4× magnification of the merge image. b, Same as a in cells expressing Mito-GFP (green, GFP). c, Same as b in cells expressing Mito-GSEC62IDR. d, Same as c in cells expressing LC3-binding-deficient Mito-GSEC62IDRLIR. e,f, Same as c and d in cells expressing Mito-GFAM134BIDR (e) and Mito-GFAM134BIDRLIR (f). g,h, Same as c and d in cells expressing Mito-GTEX264IDR (g) and Mito-GTEX264IDRLIR (h). i, Native fluorescence control of GFP expression in cells expressing constructs from ah (GFP, top). The HaloTag assay shows enhanced delivery of mitophagy reporter HMAVSTM to hydrolytically active EL upon expression of Mito-GSEC62IDR (lane 4), Mito-GFAM134BIDR (lane 6) and Mito-GTEX264IDR (lane 8), as demonstrated by the increase in Halo fragment (high contrast). N = 1 biological replicate. Bottom: the Coomassie loading control. j, LysoQuant quantification of the percentage of cellular EL that are degrading TOMM20-positive mitochondria fragments in ah (N = 3 biological replicates, n = 31, 19, 21, 29, 37, 26, 28 and 29 for ah, respectively). An ordinary one-way ANOVA with Turkey’s multiple comparisons test is shown, F = 168.8. The mean bar is shown. Adjusted P value: ****P < 0.0001; n.s., not significant (P = 0.9582). k, Transmission IEM of MEF expressing the Mito-GSEC62IDR polypeptide. Right: the micrograph shows an EL containing a mitochondrial fragment (red ‘M’). The clearance of ‘M’ is prevented by cell exposure to BafA1. Left: the micrograph shows an EL caught in the act of engulfing a mitochondrial fragment (red ‘M’). The arrowheads show gold particles used to immuno-label the Mito-GSEC62IDR polypeptide at the OMM. Scale bars, 500 nm. N = 1 biological replicate. l, Same as k in MEF, where the mitochondria display the Mito-GSEC62IDRLIR polypeptide at the OMM.

Source data

Next, the HaloTag assay in cells expressing the mitophagy reporter HMAVSTM (HaloTag tethered to the mitochondrial OMM with the 31-residue-long transmembrane domain of the mitochondrial antiviral-signalling protein (MAVS)) reports on the absence of Halo fragment in mock-transfected cells and in cells expressing Mito-GFP at the OMM (Fig. 5i, lanes 1 and 2), indicating low detectable constitutive mitophagy. Expression of ER-phagy IDR modules tethered to the OMM (Fig. 5c,e,g) induces the formation of Halo fragments (Fig. 5i, lanes 4, 6 and 8), which requires hydrolytic lysosomal activity (that is, exposure of cells to BafA1 inhibits the generation of the Halo fragment, lane 3), indicating the delivery of mitochondrial fragments to the hydrolytically active degradative compartments. Importantly, this delivery is abrogated in cells expressing LC3-binding-deficient IDR modules (Fig. 5i, lanes 5, 7 and 9), once again indicating that mitophagy requires LC3 engagement by the ER-phagy receptors’ IDR modules that have been transplanted at the limiting membrane of mitochondria.

In MEF, we also monitored the lysosomal delivery of the mitochondrial fragments generated by the expression of the Mito-GSEC62IDR polypeptide by IEM (Fig. 5k). The Mito-GSEC62IDR polypeptide immunolabelled with gold particles is seen at the OMM of mitochondria in the process of being engulfed by an EL (Fig. 5k, left) or of mitochondria within the lumen of the EL upon inactivation of hydrolytic enzymes with BafA1 (Fig. 5k, right), thus confirming the results of the CLSM analyses and of the HaloTag assay (Fig. 5c,i,j). The IEM also reveals that the mitochondrial portions captured by the LAMP1-positive EL maintain the characteristic morphology characterized by a double membrane and luminal cristae. The IEM analyses of cells that display at the OMM the Mito-GSEC62IDRLIR polypeptide (Fig. 5d) that fragments mitochondria (‘ER-phagy receptors IDRs-driven mitochondrial fragmentation’ section) but cannot engage LC3 (Extended Data Fig. 3j) reveal that these mitochondrial portions fail to be delivered within the EL and remain in the cytoplasm (Fig. 5l).

ER-phagy receptors IDRs-driven mitochondrial fragmentation

The accumulation of mitochondrial portions within LAMP1-positive EL implies that expression of IDR modules at the OMM triggers mitochondrial fragmentation. As previously shown for the ER fragmentation induced by the expression at the ER membrane of the SEC62IDR IDR module, to directly monitor the mitochondrial fragmentation triggered upon transplantation of the same IDR modules at the OMM, the experiments shown in Fig. 5b–h were repeated in MEF lacking ATG7 (Fig. 6a–g), where the absence of LC3 lipidation82 inhibits the delivery of mitochondria portions within the LAMP1-positive degradative organelles (Extended Data Fig. 4), thus preserving them in the cytoplasm. The morphology of mitochondria stained with a TOMM20-reactive antibody that decorates the OMM was first compared by CLSM in cells visible in the same coverslips that do express (Fig. 6a–g, green cells) or do not express (Fig. 6a–g, red cells) the GFP chimeras. The expression at the OMM of Mito-GFP has minor consequences on the network of mitochondria (Fig. 6a, insets 1 and 2, comparing the mitochondria in non-transfected cells with the mitochondria in the cell expressing the Mito-GFP). In cells expressing the cytoplasmic ER-phagy receptors’ IDR modules attached to Mito-GFP, the mitochondria appear smaller (Fig. 6b–g, inset 2) compared with non-transfected cells in the same coverslips (inset 1) and to cells expressing Mito-GFP. Importantly, as previously shown for the IDR modules exposed at the ER membrane, the analyses of the light microscopy (Fig. 6b–g) and of the IEM micrographs (Fig. 6h–k and quantification in Fig. 6l) confirm that the LC3-binding function of the IDR modules is dispensable for organelle fragmentation. These results were also replicated in HEK293 cells, in which mitochondria labelled with IDR modules at the OMM (Extended Data Fig. 5b–g, inset 2, and quantification in Extended Data Fig. 5h) are smaller compared with the mitochondria in cells expressing Mito-GFP (Extended Data Fig. 5a, inset 2) or non-transfected cells (Extended Data Fig. 5a–g, inset 1, and quantification in Extended Data Fig. 5h), indicating the induction of mitochondrial fragmentation by ER-phagy IDR modules transplanted at the OMM.

Fig. 6: Monitoring mitochondria fragmentation in AT7G7-KO MEF expressing the mitochondria-targeted ER-phagy receptors IDR modules.
figure 6

a, The representative CLSM micrograph shows the MEF, whose mitochondria are labelled with an antibody for TOMM20 (red). Left: the green cell has been transfected and expresses Mito-GFP at the OMM (the transfected constructs are schematically shown). Inset 1 shows the mitochondrial structure in a non-transfected cell. Inset 2 shows the mitochondrial structure in the transfected cell expressing Mito-GFP. Scale bar, 10 µm; inset magnification, 6×. b, Same as a for a representative cell that expresses Mito-GSEC62IDR (that is, the Mito-GFP displaying the SEC62 IDR module at the cytoplasmic site of the OMM). c, Same as b for a cell that expresses Mito-GSEC62IDRLIR, which does not engage LC3. d, Same as b for Mito-GFAM134BIDR. e, Same as c for Mito-GFAM134BIDRLIR. f,g, Same as b and c for Mito-GTEX264IDR (f) and Mito-GTEX264IDRLIR (g). h, RT-TEM showing mitochondria in mock-transfected cells. i, Same as h in a cell expressing Mito-GFP (the arrowheads are pointing at the gold particles marking GFP) at the OMM. j, Same as i in a cell expressing Mito-GSEC62IDR. k, Same as j in a cell expressing Mito-GSEC62IDRLIR. l, A quantification of mitochondrial cross-section area from TEM images (n = 231, 246, 449 and 493 mitochondria for hk, respectively). A Kruskal–Wallis test with a Dunn’s multiple comparisons test was performed, Kruskal–Wallis statistic of 293.6. The median bar (red) is shown. Adjusted P value: ****P < 0.0001; n.s., not significant (P = 0.0957 for mock versus Mito-GFP and P = 0.9999 for Mito-GSEC62IDR versus Mito-GSEC62IDRLIR).

IDRs-induced mitochondrial fragmentation is driven by DRP1

The fission of mitochondria that precedes delivery of the fragmented organelles to endolysosomal degradative compartments via mitophagy pathways as induced by various cues including nutrient deprivation84, hypoxia85 or oxidative stress86 is controlled by the DRP1 GTPase87,88, although DRP1-independent mitophagy has also been observed89. To assess whether DRP1 controls the mitochondrial fission as induced by the transplantation of ER-phagy receptor’s IDR modules at the OMM, Mito-GFP, Mito-GSEC62IDR, and Mito-GSEC62IDRLIR polypeptides were expressed at the OMM of wild-type MEF (Fig. 7b–d) and in MEF lacking DRP1 (DRO1 knockout (KO))90 (Fig. 7a,e–g). DRP1-KO cells have enlarged mitochondria (Fig. 7e–g, inset 1, DRP1-KO, and Fig. 7b–d, inset 1, wild-type MEF) confirming the functional KO of DRP1 leading to a general dysfunction of mitochondrial fission90. Expression of the Mito-GFP polypeptide does not affect the mitochondrial size and morphology in either wild-type or DRP1-KO MEF (Fig. 7b,e, a comparison of inset 2 with the corresponding inset 1). The expression of Mito-GSEC62IDR and Mito-GSEC62IDRLIR polypeptides induces mitochondrial fragmentation in wild-type MEF (Fig. 7c,d, respectively) as shown above for MEF (Fig. 6) and HEK293 cells (Extended Data Fig. 5) but not in DRP1-KO cells (Fig. 7f,g, a comparison of inset 2 with the corresponding inset 1). Thus, DRP1 is necessary for the mitochondrial fragmentation induced by transplantation of ER-phagy receptors IDR modules at the OMM.

Fig. 7: IDR modules fail to induce mitochondrial fragmentation in DRP1-KO cells.
figure 7

a, The western blot (WB) demonstrates the DRP1 KO (lane 2, top). GAPDH, glyceraldehyde 3-phosphate dehydrogenase. b, Monitoring mitochondria fragmentation in wild-type (WT) MEF expressing Mito-GFP at the OMM (green cell) and in non-transfected cells, whose mitochondria are labelled with an antibody for TOMM20 (red). Inset 1 shows the mitochondria in a non-transfected cell. Inset 2 shows the mitochondria in a cell expressing Mito-GFP. N = 2 biological replicates. c, Same as b for a representative cell that expresses Mito-GSEC62IDR. d, Same as c for a representative cell that expresses Mito-GSEC62IDRLIR, which does not engage LC3. Scale bar, 10 µm; inset magnification, 10×. eg, Same as bd in DRP1-KO MEF expressing Mito-GFP (e), Mito-GSEC62IDR (f) and Mito-GSEC62IDRLIR (g).

Source data

Next, we confirmed the involvement of DRP1 in the mitophagy induced by the transplantation of the FAM134BIDR, SEC62IDR or TEX264IDR IDR modules at the OMM by monitoring the lysosomal accumulation of TOMM20-positive mitochondrial portions in cells treated with BafA1. As shown in Fig. 5, in mock-transfected wild-type MEF (Extended Data Fig. 6a) and in MEF expressing the Mito-GFP chimera (Extended Data Fig. 6b) mitochondria are virtually absent from the lumen of LAMP1-positive EL, reporting on low levels of constitutive mitophagy. Transplantation of the LC3-binding-competent chimeras at the OMM of wild-type MEF enhances mitophagy (Extended Data Fig. 6c,e,g and LysoQuant quantification in Extended Data Fig. 6q, black dots), which is substantially inhibited upon mutations of the LIR that prevent LC3 engagement (Extended Data Fig. 6d,f,h and LysoQuant quantification in Extended Data Fig. 6q). In the DRP1-KO MEF, the delivery of TOMM20-positive mitochondrial portions within LAMP1-positive EL is substantially inhibited (Extended Data Fig. 6a–h versus Extended Data Fig. 6i–p and Extended Data Fig. 6q, quantifications, and Extended Data Fig. 7a versus Extended Data Fig. 7b and Extended Data Fig. 7l, quantification). This shows that DRP1 contributes to the fission of mitochondria that display the ER-phagy receptors IDR modules at their OMM, before the delivery of formed mitochondrial fragments within degradative EL.

IDRs-induced mitophagy requires the GTPase activity of DRP1

Finally, to confirm that the GTPase activity of DRP1 controls the mitophagy programme elicited by exposure of ER-phagy receptors IDR modules at the OMM, the active (mCherry–DRP1), or the inactive forms of the GTPase (mCherry–DRP1K38A)91 were back-transfected in the DRP1-KO MEF. The analyses show that the back-transfection of the active form of DRP1 partially restores the capacity of the SEC62, FAM134B and TEX264 IDR modules competent for LC3 engagement to trigger mitophagy (Extended Data Fig. 7c,f,i,l, respectively) but the back-transfection of the inactive GTPase DRP1K38A does not (Extended Data Fig. 7d,g,j,l). As expected, reconstitution of the DRP1 activity does not activate mitophagy, if the IDR modules cannot engage LC3 (Extended Data Fig. 7e,h,k,l). Notably, the fissionase DRP1 is not involved in ER-phagy programmes induced by ER-phagy IDR modules (Extended Data Fig. 8).

Expression of the FUNDC1 IDR at the OMM triggers mitophagy

The conservation amongst organellophagy receptors of membrane-tethered IDR modules with net cumulative negative charge led us to postulate a functional conservation that would allow heterologous transplantation to trigger autophagic regulation of a given organelle on demand. So far, we demonstrated that the IDR modules of ER-phagy receptors trigger mitophagy when transplanted at the OMM. Are IDR modules of mitophagy receptors (for example, of FUNDC1 (refs. 13,14)) competent for ER-phagy induction when transplanted at the ER membrane?

First, we assessed dispensability of the FUNDC1 tri-spanning membrane-tethering part in mitophagy induction. As shown above for the ER-phagy receptors, also for FUNDC1 the substitution of the original membrane anchor with a dissimilar transmembrane domain (the membrane anchor of the mitochondrial protein MAVS) does not affect the capacity of the polypeptide to control generation and delivery of TOMM20-positive mitochondrial portions within LAMP1-positive EL (Fig. 8a,b,d). The inactivation of the LC3-engaging function of the LIR embedded in the FUNDC1IDR-GMAVS module upon mutation of the -YEVL- tetrapeptide to -AAAA-, substantially inhibits mitophagy induction (FUNDC1IDRLIR-GMAVS) (Fig. 8c,d).

Fig. 8: Transplantation of the IDR module of the mitophagy receptor FUNDC1 at the mitochondrial membrane triggers mitophagy and at the ER membrane triggers ER-phagy.
figure 8

a, A representative green MEF expressing OMM-anchored GFP (GMAVS, the constructs used for these experiments are tethered at the OMM with the transmembrane domain of the mitochondrial protein MAVS). Wild-type MEF were exposed to BafA1 to preserve mitochondria fragments (labelled with TOMM20, red) when delivered within LAMP1-positive EL (cyan). Scale bar, 10 µm; inset magnification, 4×. b, Same as a for a green cell expressing FUNDC1IDR-GMAVS (left inset: the LAMP1-positive EL contain TOMM20-positive mitochondrial fragments) and a non-transfected black cell (right inset: whose LAMP1-positive compartment does not contain mitochondrial fragments). c, Same as b for cells expressing FUNDC1IDRLIR-GMAV deficient in LC3 binding. d, LysoQuant quantification of the cells in ac (N = 2 biological replicates; n = 13, 13 and 10 cells for ac, respectively). An ordinary one-way ANOVA with a Dunnett’s multiple comparisons test was performed, F = 106.5. The mean bar is shown. Adjusted P value: ****P < 0.0001; n.s., not significant (P = 0.4462). eg, Same as ac for ER-targeted GFP (GT17) (e), FUNDC1IDR-GT17 (f) and FUNDC1IDRLIR-GT17 (g) constructs. h, LysoQuant quantification, N = 2 biological replicates; n = 11, 11 and 12 cells for eg, respectively. An ordinary one-way ANOVA with Dunnett’s multiple comparisons test was performed, F = 40.35. The mean bar is shown. Adjusted P value: ****P < 0.0001; n.s., not significant (P = 0.5726). i, In gel GFP fluorescence (top) and the corresponding immunoprecipitation (IP)–western blot (WB) (bottom) showing the engagement of LC3B by ER-targeted IDRs of SEC62 and FUNDC1 expressed in wild-type MEF. N = 1 biological replicate for lanes 5–7 and N = 3 for lanes 1–4.

Source data

Expression of the FUNDC1 IDR at the ER triggers ER-phagy

Next, the IDR module of the mitophagy receptor FUNDC1 was targeted and anchored at the ER membrane with a conventional 17-residue membrane anchor (the T17 used above) (Fig. 8f). The ER-targeted FUNDC1IDR-GT17 engages lipidated LC3B-II as shown by co-immunoprecipitation (Fig. 8i, lane 6, compared with the LC3-II engagement by the membrane-anchored IDR module of the ER-phagy receptor SEC62, lane 3). LC3 engagement is abolished upon mutation of the -YEVL- tetrapeptide of FUNDC1 to -AAAA- (Fig. 8i, lane 7). The expression of FUNDC1IDR-GT17 substantially enhances the delivery of CNX-positive ER fragments within the LAMP1-positive EL (GT17) (Fig. 8f,h) compared with the expression of ER-targeted GFP (GT17) (Fig. 8e,h). The inactivation of the LC3-engaging function of the FUNDC1 IDR module transplanted at the ER membrane substantially inhibits the delivery of ER portions within LAMP1-positive EL (Fig. 8g,h).

Conservation of features, net cumulative negative charge

To close the loop and go back to the functional conservation of cytoplasmic IDR modules among organellophagy receptors (Fig. 1), we analysed the capacity of the IDR of REEP1 (refs. 92,93) to fragment mitochondria, when targeted at the OMM. REEP1 is member of a conserved family of ER remodelling proteins that generate high ER membrane curvature. It displays a C-terminal IDR module of 51 residues, a length that is in the range of sizes observed for the IDR modules of organellophagy receptors (Fig. 1d). However, the IDR module of REEP1 is characterized by a net cumulative positive charge of 4.03 (Fig. 1e). In contrast to the IDR modules of ER-phagy and mitophagy receptors tested in this work, the transplantation of REEP1IDR at the OMM does not trigger mitochondria fragmentation (Extended Data Fig. 9a,b), even though this module is expressed at much higher level (Extended Data Fig. 9c, lane 11) than the corresponding modules derived from the ER-phagy receptors (Extended Data Fig. 9c, lane 8) that induce mitochondria fragmentation. Notably, the addition in the REEP1 IDR module of a nonapeptide containing the extended LIR sequence of SEC62 (-GNDFEMITK-) results in poor engagement of LC3, both when the REEP1 IDR module is expressed at the ER membrane (GT17-REEP1IDRFEMI) (Extended Data Fig. 9c, lane 5) or at the mitochondrial membrane (Mito-GREEP1IDRFEMI, lane 10). Not surprisingly, therefore, the expression of the IDR module of REEP1 at the OMM or at the ER membrane does not induce mitochondrial (Extended Data Fig. 9d–h) nor ER delivery (Extended Data Fig. 9f–i) to the degradative LAMP1 compartment.

Conservation of features, LIR distance from the membrane

As shown above, the engagement of LC3 proteins is dispensable for the organelle fragmentation function of the IDR modules of organellophagy receptors. However, it is required to execute the delivery of organelle portions within the degradative compartments. To monitor how the distance from the membrane of the LIR impacts on organellophagy, we made use of the ER-exposed IDR module of SEC62. The full-length IDR module (GT17-GSEC62IDR148 in Extended Data Fig. 10a) has a total length of 148 residues (including a 4-residue-long linker between the IDR and the T17 transmembrane domain) and has 111 residues between the end of the membrane anchor and the LIR. This distance was progressively reduced to 55 (GT17-GSEC62IDR92), 28 (GT17-SEC62IDR65) and 10 residues (GT17-SEC62IDR47) (Extended Data Fig. 10b–d). Analyses by CLSM show that the induction of ER-phagy is maintained by the GT17-GSEC62IDR92 and the GT17-SEC62IDR65 modules (Extended Data Fig. 10b,c,f, quantification of ER delivery to the degradative LAMP1-positive EL). The delivery of CNX-positive ER portions within EL drops substantially on ER expression of the GT17-SEC62IDR47 module that fails to engage LC3 proteins (Extended Data Fig. 10g), possibly because the short distance of the LIR from the lipid bilayer, 10 residues, impedes the access of LC3 proteins.

Conservation of features, length of the IDR modules

All the IDR modules examined in these experiments conserve the net negative charge (−19.95 for GT17-GSEC62IDR148 and for GT17-GSEC62IDR92, −16.00 for GT17-SEC62IDR65 and −14.06 for GT17-SEC62IDR47) and would have a length consistent with the length of cytoplasmic IDR modules displayed by organellophagy receptors (Fig. 1d, the shortest IDR module tested in our experiments is the GT17-SEC62IDR47, with a total length of 47 amino acids that, despite the incapacity of engaging LC3 proteins, could be competent to induce organelle fragmentation).

To assess how the length of the IDR modules affects their capacity to induce organelle fragmentation, we progressively reduced the length of the SEC62 IDR modules exposed on a sfGFP moiety at the limiting membrane of mitochondria (Extended Data Fig. 10h–m). Our tests show that only the Mito-GFP23 IDR has lost the capacity to fragment the organelle, when exposed at the OMM (Extended Data Fig. 10h,m). This IDR maintains the net cumulative negative charge at physiological pH (−1.03). However, it is shorter—about half the length—of the shortest organellophagy receptors known so far (SAMM50 and FUNDC1) (Fig. 1d).

Discussion

Delivery of organelle portions to degradative compartments requires the engagement of LC3 proteins by membrane-bound organellophagy receptors. An open question in the field is how the organelle portions to be removed from the cell are physically separated from the bulk of the organelle that must be preserved. Seminal studies on ER-phagy receptors of the FAM134 family (FAM134A, FAM134B and FAM134C) established that their transcriptional induction, phosphorylation, ubiquitylation and homo-/hetero-oligomerization control ER fragmentation and lysosomal clearance7,24,25,27,38,53,55,94,95. FAM134 proteins are anchored at the ER membrane via a RHD, a membrane-tethering module found in ER shaping proteins of the reticulon and REEP families that generates high curvature and constrictions of the ER membrane30,70,71,72,73,74,75,76,77,78,79. The capacity of the FAM134B-RHD to remodel the ER membrane has been highlighted by molecular dynamics simulations and in vitro liposome remodelling and has been proposed to promote the ER fragmentation required for lysosomal clearance of select ER portions7,23,24,25,26,27,28. During revision of our manuscript, the same group reported that molecular dynamics simulations revealed that the IDR module of FAM134B might enhance the capacity of the RHD of FAM134B to fragment the ER96. Notably, the vast majority of organellophagy receptors are anchored at the membrane of their homing organelle (the ER, the mitochondria or the Golgi complex), via conventional multi- or single-spanning transmembrane domains that do not share the membrane remodelling function of RHD modules (Fig. 1). Thus, a model assuming that the membrane-tethering modules of organellophagy receptors determine or give essential contribution to organelle fragmentation cannot be generalized. As shown in Fig. 1, the cytoplasmic IDR modules with net cumulative negative charge are a shared trait of autophagy receptors at the surface of organelles that rely on fragmentation for homoeostatic control. Our work highlights the functional conservation of the cytoplasmic IDR modules of membrane-tethered organellophagy receptors in promoting the organelle fragmentation, which is a conditio sine qua non for the execution of the autophagic programmes that regulate size, activity and homoeostasis of the organelles in our cells. We report that (1) mammalian ER-phagy and mitophagy receptors expose at the cytoplasmic face of their homing organelle a functionally conserved IDR module with diverse primary sequence, a length between 47 and 250 residues, a net cumulative negative charge at physiologic pH and a LIR separated by at least 24 residues from the membrane of the organelle (mammalian Golgiphagy receptors and yeast ER-phagy and mitophagy receptors, whose function has not been analysed here, also expose these modules); (2) the expression of full-length ER-phagy receptors recapitulates ER fragmentation and lysosomal delivery independent of the ER remodelling capacity of their membrane-anchoring modules and bypassing the requirement for external triggering signals; (3) the membrane-anchoring modules of the three ER-phagy receptors analysed in this study (FAM134B, SEC62 and TEX264) determine the suborganelle distribution of the receptors but are dispensable for ER fragmentation and execution of the ER-phagy programme. Their substitution with an unrelated transmembrane domain has no impact on the induction of ER fragmentation and ER-phagy; (4) likewise, the membrane-anchoring module of the mitophagy receptor FUNDC1 can be replaced by an unrelated sequence that targets the IDR module at the OMM, with no consequences on activation of mitochondrial fragmentation and mitophagy; (5) tethering the IDR modules of ER-phagy receptors at the OMM induces mitochondrial fragmentation driven by the DRP1 fissionase and mitophagy; (6) tethering the IDR module of the mitophagy receptor FUNDC1 at the ER membrane triggers ER fragmentation and ER-phagy; (7) the engagement and lipidation of LC3 proteins is dispensable for organelle fragmentation but required for delivery of the organelle portions within LAMP1-positive degradative organelles; (8) finally, the non-compliance with features conserved amongst organellophagy receptors (that is, change from net cumulative negative to positive charge, reduction in size or in the distance of the LIR from the membrane) negates the capacity of the cytoplasmically exposed IDR modules to fragment the organelles and to deliver organelle portions to degradative compartments.

Negatively charged IDRs are common in the proteomes of nucleated cells, where they are mainly found in long aspartic and glutamic acid repeats97. Organellophagy receptors IDR modules seem to be characterized by more uniform negative charge distribution along their sequence, which can be further amplified by post-translational modifications such as phosphorylation that has been reported as an activation signal for Metazoan’s ER-phagy receptors53,54,55,95,98,99 and receptors controlling autophagic turnover of other organelles100,101,102,103 (reviewed in ref. 104 for Fungi). Another peculiarity of IDR modules of organellophagy receptors is obviously the presence of LIR motifs that, upon activation, engage components of the autophagy machinery. It should not be considered a coincidence that the LIR located closer to a lipid bilayer is the one of FUNDC1, placed 24 residues apart. In our tests, the progressive shortening of the distance of the LIR from the membrane clearly generates spatial constraints for the engagement of LC3 proteins. Calculating an elongated structure and an estimated average length for a single amino acid of 0.38 nm (ref. 62), the GT17-SEC62IDR65 module places the LIR at a distance of 28 residues from the membrane (that is, an estimated 10.64 nm that still allows LC3 engagement). By contrast, for the GT17-SEC62IDR47 module the LIR is placed at 10 residues (that is, 3.8 nm) from the lipid bilayer, a distance too short to accommodate an LC3 molecule bound to the IDR. This was confirmed in cellula, where the shortened IDR modules progressively lost the capacity to engage LC3 proteins and to deliver ER portions within degradative compartments. Clearly, the shortening of the IDR module also eliminates domains outside the LIR that contribute to the stable association with lipidated LC3.

For IDR-driven mitochondrial fragmentation our data reveal the intervention of the fissionase and GTPase DRP1, whose involvement in the fragmentation of mitochondria that precedes mitophagy has been previously reported13,84,85,86,87,88,90. The identity and/or the involvement of a GTPase that contributes with the ER-phagy receptors in the fragmentation of the ER, if any, remains to be established. The combination of a membrane-tethering module that specifies and pre-remodels the organelle and the suborganellar portion to be removed from cells8,9,10,11,81 and of a functionally conserved IDR module that facilitates organelle fragmentation and engages cytosolic autophagy gene products to deliver organelle portions to the degradative compartments builds an elegant and modulable sensor to adapt organelle size and function to cellular needs.

The capacity to control the integrity of organelles and the lysosomal clearance of select portions of organelles may find applications in the treatment of diseases associated with dysfunctional regulation of organelle size and activity. For example, the enhanced expression of ER-phagy receptors and the resulting hyperactivation of constitutive ER-phagy render tumour cells more resistant to cellular stresses such as those induced upon therapeutic interventions105,106,107,108,109. Giant and megamitochondria have been described by pathophysiologists as early hallmarks of human disorders including liver diseases110,111, cardiomyopathies112 and alcohol-induced heart disease113,114 as well as in pathophysiological conditions such as ageing115,116,117, which leads to organelle dysfunction. Other organelles may also be affected by gigantism: pathological ER expansion due to chronic ER stress is a hallmark of metabolic and of ER storage disorders118,119, while giant peroxisomes are present in hepatic tissues of patients affected with rhizomelic chondrodysplasia punctata and acyl-CoA oxidase deficiency120.

Our work leads the way to develop organelle-targeting chimeras (ORGATACs), where an organelle-targeting signal is fused to a short IDR sequence that conserves the functional features of organellophagy IDR modules. Organelle-targeting chimeras may favour organelle fragmentation (in the absence of engagement of the autophagic machinery) or organelle fragmentation and turnover (upon engagement of LC3 proteins). This is expected to alleviate the symptoms of diseases characterized by organelle dysfunction also related to ageing, intraorganelle accumulation of harmful macromolecules including misfolded proteins, and to promote de novo biogenesis of functional replacements. All in all, our study offers a method to control integrity and activity of intracellular organelles by surface activation of IDR modules with net negative charges. It highlights a remarkable example of functional conservation on sequence divergency that would support a model, where IDRs characterized by different protein primary structure may retain biophysical features that are important for their function121 and paves the way to study the evolution of IDR modules to control organellar homoeostasis across species.

Methods

Cell culture, transient transfection and inhibitors

MEF and human embryonic kidney 293 (HEK293) cells were cultured in DMEM supplemented with 10% foetal calf serum (FCS, Dubco) at 37 °C in a 5% CO2 atmosphere. Transient transfections were carried out using jetPRIME transfection reagent (PolyPlus) according to the manufacturer’s instructions. Wild-type and ATG7-KO MEF are a kind gift from M. Komatsu. Wild-type and DRP1-KO MEF are a kind gift from Mike Ryan and Susanna Manley. BafA1 (Calbiochem) was used at 50 nM for 15 h if not otherwise specified. HEK293 were purchased from ATCC (CRL-1573). ATG7-KO were checked for absence of ATG7 and for lack of LC3 lipidation (for example, refs. 8,82,122). DRP1-KO MEFs were checked for absence of DRP1 and enlarged mitochondria. Wild-type MEF cells resulted positive for DRP1 and ATG7, displayed classical fibroblast morphology and were positive for LAMP1 staining with mouse-specific LAMP1 antibody. HEK293 were obtained from ATCC, and their identity was confirmed by morphology.

Expression plasmids and antibodies

ER-targeted IDR constructs of ER-phagy receptors were subcloned in a pcDNA3.1(+) backbone with an N-terminal sfGFP or HALO tag, an inactive bacterial hydrolase that covalently binds cell permeable ligands coupled to fluorescent probes58. The ER targeting of ER-phagy receptors’ IDR portions was achieved by incorporating an N-terminal prolactin signal sequence, followed by sfGFP, -AGG-TPSETLITTVESNSSW- linker derived from the mouse Cyb5a protein and a -T17 transmembrane anchor (-WTNWVIPAISALVVALM-) linker with the -YRGS- cytosolic flanking sequence. Constructs containing transmembrane domain modules were fused with a C-terminal cytosolic GFP or HALO moiety preceded by -AAAGT- or -AAASGAGS- linkers, respectively. ER-targeting of FUNDC1 IDR–GFP and GFP control constructs was achieved by adding the T17 sequence at the C-terminal (-WTNWVIPAISALVVALM-) preceded by the sfGFP-GGS-PSETLITTVESNSSW- linker. Mitochondrial targeting of ER-phagy IDRs was achieved by fusing the first 33 amino acids of the human TOMM20 protein to the N-terminus, followed by a -GPVAT- linker, sfGFP, and the IDRs of ER-phagy receptors. Mitochondrial targeting of the FUNDC1 IDR–GFP and GFP control constructs was achieved by adding the transmembrane sequence of MAVS (-RPSPGALWLQVAVTGVLVVTLLVVLYRRRLH-) at the C-terminus, preceded by AAAA-GA-sfGFP and -GGS-PSETLITTVESNSSW- linker. The extended LIR sequence of SEC62 (-GNDFEMITK-) was generated by replacing the QP residues in the REEP1 IDR sequence -GQPK- with -NDFEMIT- to create REEP1IDRFEMI. The sequences of IDRs and the corresponding linkers, cumulative charges and lengths are summarized in Supplementary Table 1. The antibodies used in this study, along with their respective dilutions, are listed in Supplementary Table 2.

Cell lysis and western blot

Following the respective treatments, MEF were washed with ice-cold phosphate-buffered saline (PBS) containing 20 mM N-ethylmaleimide (NEM). The cells were then lysed using either 2% CHAPS (in HEPES-buffered saline (HBS), pH 6.8) or RIPA buffer (1% Triton X-100, 0.1% SDS, 0.5% sodium deoxycholate in HBS, pH 7.4), both supplemented with 20 mM NEM and protease inhibitors (200 mM phenylmethylsulfonyl fluoride, 16.5 mM chymostatin, 23.4 mM leupeptin, 16.6 mM antipain, 14.6 mM pepstatin) for 20 min on ice. The postnuclear supernatant (PNS) was obtained by centrifugation at 10,600gfor 10 min at 4 °C. The PNS was denatured by adding 100 mM dithiothreitol (DTT) and heated for 5 min at 95 °C before being subjected to SDS–polyacrylamide gel electrophoresis (PAGE). For in gel GFP-fluorescent assays, the PNS supplemented with DTT was kept for 5 min at room temperature (RT). GFP-fluorescent SDS–PAGE gels were scanned with on the Amersham Typhoon scanner (Cytiva) with 488 nm laser and 525BP20 filter. HaloTag(TMR)-fluorescent SDS–PAGE gels were scanned with the same instrument with 532 nm laser and 570BP20 filter. The protein bands were then stained with Coomassie or transferred onto polyvinylidene difluoride membranes using the Trans-Blot Turbo Transfer System (Bio-Rad). The membranes were blocked with 8% (w/v) non-fat dry milk (Bio-Rad) in Tris-buffered saline containing 1% Tween 20 (TBS-T, Sigma-Aldrich) and incubated overnight with primary antibodies diluted in TBS-T. Afterward, horseradish peroxidase (HRP)-conjugated protein A diluted in TBS-T was applied for 45 min. The protein bands were visualized using the WesternBright Quantum detection system (Advansta), and the signals were captured with the FusionFX chemiluminescence imaging system (VILBER/Witec). The quantification of western blot bands was performed using Fusion FX Edge 18.12 and ImageJ 2.16.0/1.54p software123.

Protein cross‐linking with DSP

After treatment, the cells were washed with PBS and incubated with 1 mM dithiobis-succinimidyl propionate (DSP) (Thermo Fisher Scientific) (prepared from a 100× stock in dimethylsulfoxide) in PBS for 30 min at RT. The reaction was quenched by adding 1 M Tris (pH 7.8) to a final concentration of 20 mM, followed by a 15-min incubation at RT. The cells were then washed with PBS, treated with 20 mM NEM and lysed using RIPA buffer (1% Triton X-100, 0.1% SDS, 20 mM NEM, 0.5% sodium deoxycholate in HBS, pH 7.4) for 20 min on ice. The PNS were collected by centrifugation at 10,600gfor 10 min and used for immunoprecipitation of IDR chimera–LC3 complexes.

Affinity purification-liquid chromatography/mass spectrometry

The HEK293 cells were transfected with GFP-tagged TMD/RHD, SEC62/SEC62LIR or GT17-SEC62IDR/IDRLIR chimeras. Fifteen-hour post-transfection, cells were treated with 100 nM BafA1 for 6 h, crosslinked with DSP as described above, and the supernatant was collected. The protein complexes were isolated with 100 µl GFP–TRAP (Chromotek) following manufacturer’s protocol. The samples were digested on beads following a modified version of the iST method (named miST method). A total of 25 µl of miST lysis buffer (1% sodium deoxycholate, 100 mM Tris pH 8.6, 10 mM DTT), were added to the beads. After mixing and dilution 1:1 (v:v) with H2O, the samples were heated 5 min at 75 °C. The reduced disulfides were alkylated by adding 13 µl of 160 mM chloroacetamide (33 mM final) and incubating for 45 min at 25 °C in the dark. After digestion with 0.5 µg of trypsin/LysC mix (Promega #V5073) for 2 h at 25 °C, the sample supernatants were transferred in new tubes. To remove sodium deoxycholate, two sample volumes of isopropanol containing 1% TFA were added to the digests, and the samples were desalted on a strong cation exchange plate (Oasis MCX; Waters) by centrifugation. After washing with isopropanol/1% TFA, peptides were eluted in 200 µl of 40% MeCN, 59% water and 1% (v/v) ammonia and dried by centrifugal evaporation.

Tryptic peptide mixtures were injected on a Vanquish Neo nanoHPLC system interfaced via a nanospray Flex source to a high resolution Orbitrap Exploris 480 mass spectrometer (Thermo Fisher). The peptides were loaded onto a trapping microcolumn PepMap100 C18 (5 mm × 1.0 mm ID, 5 μm, Thermo Fisher) before separation on a C18 custom packed column (75 μm ID × 45 cm, 1.8 μm particles, Reprosil Pur, Dr. Maisch), using a gradient from 2% to 80% acetonitrile in 0.1% formic acid for peptide separation at a flow rate of 250 nl min−1(total time 130 min). Full MS survey scans were performed at 120,000 resolution. A data-dependent acquisition method controlled by Xcalibur software (Tune 2.9, Thermo Fisher Scientific) was used that optimized the number of precursors selected (‘top speed’) of charge 2+ to 5+ while maintaining a fixed scan cycle of 2 s. The peptides were fragmented by higher energy collision dissociation with a normalized energy of 30% at 15,000 resolution. The window for precursor isolation was of 1.6 m/zunits around the precursor and selected fragments were excluded for 60 s from further analysis. The intensity values were obtained following MaxQuant (V. 2.1.4.0)124 analysis. Only the proteins with at least two detected peptides were considered for analyses. The results were normalized by median abundance, the missing values were imputed from a normal distribution of 1.8 standard deviation down shift and with a width of 0.3 of each sample, and unpaired two-tailed tests were used to calculate the Pvalue. Data analyses and graph plotting were done with the Perseus platform (version 2.0.5)125 and MATLAB (The MathWorks, R2023b Update 5 23.2.0.24591. The raw data are deposited in the Pride database (project accession PXD060519).

CLSM

MEFs were seeded onto alcian blue-coated (Sigma) glass coverslips (VWR) and transiently transfected using jetPRIME reagent following the manufacturer’s protocol. For LysoQuant analysis, 8 h post transfection, the cells were treated with 50 nM BafA1 for 15 h. Moreover, the cells transfected with HaloTag-fusion proteins were incubated with 100 nM TMR HaloTag ligand (Promega). A total of 24 h post transfection, the cells were fixed at RT for 20 min using 3.7% formaldehyde in PBS. To permeabilize the membranes, coverslips were incubated for 20 min in a permeabilization solution containing 10% goat serum, 10 mM HEPES, 15 mM glycine and 0.05% saponin. After permeabilization, the cells were incubated with primary antibodies diluted in permeabilization solution (as specified in Supplementary Table 2) for 120 min. Following three washes in permeabilization solution, the cells were then incubated with Alexa Fluor-conjugated secondary antibodies diluted 1:300 in permeabilization solution for 45 min. The cells were rinsed three times with permeabilization solution and water, then mounted onto glass microscope slides (Epredia) using a drop of Mount Liquid anti-fade (Abberior). Confocal images were captured using Leica TCS SP5, STELLARIS 5 and STELLARIS 8 microscopes equipped with a Leica HCX PL APO lambda blue 63×/1.40 oil objective and a pinhole set at 1 a.u. Image acquisition was performed with Leica LAS X software, utilizing diode at 405 nm or laser beams at 489, 499, 552, 561, 587 and 653 nm wavelengths for excitation. Fluorescence emissions were collected at the following ranges: 430–490 nm (Alexa Fluor 405), 494–557 nm (GFP), 504–587 nm (Alexa Fluor 488), 557–663 nm (TMR), 592–644 nm (Alexa Fluor 568) and 658–750 nm (Alexa Fluor 646). Image analysis and quantification were performed using LysoQuant and ImageJ 2.16.0/1.54p software64,123. Image post-processing was performed with Adobe Photoshop (v26.2.0).

RT-TEM and electron tomography

MEFs were plated on gridded glass-bottom dishes (MatTek Corporation) and transiently transfected using jetPRIME reagent following the manufacturer’s protocol. A total of 24 h after transfection, the cells were prefixed with a 4% formaldehyde EM-grade solution supplemented with 0.1% glutaraldehyde. For morphological ER analyses, the coordinates of the cells on the finder grid were determined using wide‐field microscopy on the Leica STELLARIS 8 microscope with Leica LAS X 4.5.0.025531 software with Leica PL APO 10× 0.40 air objective with pinhole 2 a.u., and the transfected and non-transfected cells were identified based on GFP fluorescence (493–556 nm range). The cells were then fixed with a solution containing 2.5% glutaraldehyde in 0.1 M sodium cacodylate buffer (pH 7.4). After several washes in sodium cacodylate buffer, the cells were post-fixed in 1% osmium tetroxide (OsO4), 1.5% potassium ferricyanide (K4(Fe(CN)6)) in 0.1 M sodium cacodylate buffer for 1 h on ice, washed with distilled water and stained en bloc with 0.5% uranyl acetate in distilled water overnight at 4 °C in the dark. The samples were then rinsed in distilled water, dehydrated with increasing concentrations of ethanol and embedded in Epoxy resin (Sigma-Aldrich). After curing for 48 h at 60 °C, ultrathin sections (70–90 nm thickness) were collected using an ultramicrotome (UC7, Leica microsystem), stained with uranyl acetate and Sato’s lead solutions and observed under a Transmission Electron Microscope Talos L120C (FEI, Thermo Fisher Scientific) operating at 120 kV. The images of transfected and non-transfected cells were acquired with a Ceta CCD camera (FEI, Thermo Fisher Scientific). For three-dimensional serial section electron tomography, serial sections (130–150 nm thickness) were collected on formvar-carbon coated slot grids, tilted images series (+60°) were acquired with a Talos L120C TEM using Tomography 5 software (FEI, Thermo Fisher Scientific). The tilted images were aligned, and tomograms reconstructed using IMOD software (v. 4.11.24) (organelle segmentation was performed in Microscopy Image Browser (MIB, v. 2.84 (ref. 126)) and visualized in IMOD v4.11.24 (ref. 127)).

Immunogold electron microscopy

MEFs were seeded onto glass-bottom dishes (MatTek Corporation) and transiently transfected with GFP-tagged chimeras using jetPRIME reagent, following the manufacturer’s instructions. A total of 8 h after transfection, the cells were either treated with 50 nM BafA1 for 15 h and then fixed for 2 h in periodate-lysine-paraformaldehyde128 (FUJIFILM Wako) at RT or fixed 25 h post-transfection without treatment. After the fixative was removed by washing with 1× PBS, the cells were incubated with 50 mM glycine and blocked for 30 min in a blocking solution (0.2% bovine serum albumin, 5% goat serum, 50 mM NH4Cl, 0.1% saponin, 20 mM phosphate buffer, 150 mM NaCl) at RT. The cells were stained with primary rabbit anti-GFP antibody (Abcam) and gold-labelled secondary antibodies (Nanoprobes) in the blocking buffer at RT. Afterwards, the cells were refixed for 30 min in 1% glutaraldehyde, and the nanogold particles were enhanced using a gold enhancement solution (Nanoprobes) as per the manufacturer’s protocol. The cells were post-fixed with osmium tetroxide (OsO4) and processed for electron microscopy. The samples were then rinsed with distilled water, dehydrated through a graded ethanol series and embedded in epoxy resin (Sigma-Aldrich). After curing for 48 h at 60 °C, ultrathin sections (70–90 nm) were cut using an ultramicrotome (UC7, Leica Microsystems), stained with uranyl acetate and Sato’s lead solutions. The images were captured using a Ceta CCD camera (FEI, Thermo Fisher Scientific) and Velox 3.6.0 software (FEI, Thermo Fisher Scientific) on a Talos L120C TEM (FEI, Thermo Fisher Scientific) operating at 120 kV. For live FRAP analyses, ATG7-KO MEF expressing GFP–KDEL and HaloTag fusion proteins were imaged for 50 frames before bleach, then the GFP signal was bleached by 20 pulses of 405 diode at 100% intensity and imaged post-bleaching for 500 frames with the frame rate of 0.261 s. The bleaching and intensity measurements were done over a peripheral ER area of 29 µm2. The intensity values were then normalized to prebleach measurements, and the maximum normalized postbleach value was used to assess ER fragmentation.

Statistical analyses, data acquisition and blinding

The statistical comparisons and graphical plots were performed using GraphPad Prism 10 (GraphPad Software, version 10.1.2 for Windows). A data analysis for proteomics data was performed in Perseus v2.0.5. Tests employed for statistical analysis are reported in figure legends. Data distributions (individual points) are always shown. Whenever data distribution was not assumed to be normal, an appropriate statistical test was used to take it into account. An adjusted P value <0.05 (for one-way and two-way analysis of variance (ANOVA) with multiple comparison tests) was considered statistically significant. The ANOVA test results were corrected for multiple comparisons. All t-tests performed are two-sided. All experimental replicates represent independent biological replicates. Figure legends specify the number of cells, EL or mitochondria analysed (n) and the number of independent biological replicates of the experiment (N). No statistical methods were used to predetermine sample sizes, but our sample sizes are similar to those reported in previous publications57,64,65,129,130. No randomization was performed as this is not common for western blot or microscopy analysis. The covariates were controlled with the corresponding negative controls.

Unbiased imaging data collection/analyses were performed by at least two different scientists, one of which was blind to the identity of the sample. Morphological analyses of mitochondrial size were performed by the scientists blinded to the identity of the sample. The fluorescent image quantifications of ER and mitochondria delivery to ELs were performed using LysoQuant, an unbiased and automated deep learning tool. Acquisition of MS data was done by scientist blinded to the nature of the sample and the scope of the experiment. For western blot and immunoprecipitation analyses, conclusions were drawn based on qualitative presence/absence of band signal; therefore, blinding is not relevant. For electron microscopy, acquisition of samples was performed by a scientist blinded to the nature of the sample. No data were excluded from the analyses.

Reporting summary

Further information on research design is available in the Nature Portfolio Reporting Summary linked to this article.